Provided by Tiger Trade Technology Pte. Ltd.

Day One Biopharmaceuticals Inc.

10.60
-0.0500-0.47%
Post-market: 10.600.00000.00%16:15 EST
Volume:1.41M
Turnover:14.92M
Market Cap:1.09B
PE:-7.19
High:10.69
Open:10.63
Low:10.44
Close:10.65
52wk High:13.20
52wk Low:5.64
Shares:103.30M
Float Shares:78.77M
Volume Ratio:0.58
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4748
EPS(LYR):-1.0243
ROE:-22.74%
ROA:-14.64%
PB:2.48
PE(LYR):-10.35

Loading ...

Oct 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities